個人簡介
陸明,博士,副教授。2007年畢業于中山大學,高分子物理與化學專業,獲博士學位,留校從事藥劑學研究。2015-2016年赴美國普渡大學太阳集团1088vipDr. Lynne S. Taylor課題組進行合作研究。研究興趣為熱熔擠出制劑技術、藥物過飽和溶液的相行為和藥物固态化學研究。研究成果主要發表在Angewandte Chemie, Chemical Communications, Communications Chemistry, Crystal Growth&Design, International Journal of Pharmaceutics, Pharmaceutical Research等藥劑學、化學和晶體學主流期刊上。擔任上述期刊審稿人,任中國晶體學會藥物晶體學專業委員會理事。
ORCID: https://orcid.org/0000-0002-2622-1528
ResearchGate: https://www.researchgate.net/profile/Ming_Lu26
Google Scholar: https://scholar.google.com/citations?user=Cl0aa6IAAAAJ&hl=en
代表性專著章節
1. Ming Lu. Chapter 9. Novel excipients and materials used in 3D printing of pharmaceutical dosage forms. 3D and 4D printing in biomedical applications: Process engineering and additive manufacturing. Editor: Mohammed Maniruzzaman. Publisher: John Wiley, UK, 2019.
2. Ming Lu. Chapter 10: Continuous cocrystallization of poorly soluble APIs to enhance dissolution. Practical guide to hot-melt extrusion: continuous manufacturing and scale-up methodologies. Editor: Mohammed Maniruzzaman. Publisher: SmithersRapra, UK, 2015.
代表性論文
1. Molly Lightowler+, Shuting Li+, Xiao Ou, Jungyoun Cho, Ao Li, Gerhard Hofer, Jiaoyan Xu, Taimin Yang, Xiaodong Zou, Ming Lu*, Hongyi Xu*. Phase identification and discovery of an elusive polymorph of drug-polymer inclusion complex using automated 3D electron diffraction. Angewandte Chemie International Edition, 2024, e202317695. https://doi.org/10.1002/anie.202317695.
2. Binbin Liu+, Changrui Li+, Ziqiao Chena, Xiao Oua, Shuting Lia, Ao Lia, Pin Chen*, Ming Lu*.Molecular insights into the formation of drug-polymer inclusion complex. International Journal of Pharmaceutics, 2024, 652(5): 123761. https://doi.org/10.1016/j.ijpharm.2023.123761
3. Shuting Li, Binbin Liu, Xiao Ou, Haowei Rong, Ming Lu*. Ritonavir revisited: Melt crystallization can easily find the late appearing polymorph II and unexpectedly discover a new polymorph III. Molecular Pharmaceutics, 2023, 20, 8: 3854–3863. https://doi.org/10.1021/acs.molpharmaceut.2c00994
4. Shuting Li,+ Molly Lightowler,+ Xiao Ou, Siyong Huang, Yifan Jiang, Xizhen Li, Xiaodong Zou, Hongyi Xu,* Ming Lu*. Polymorphism of vemurafenib: Direct structure determination from spherulites using 3D electron diffraction. Communications Chemistry, 2023, 6:18. https://doi.org/10.1038/s42004-022-00804-2
5. Ao Li, Shuting Li, Jiashu Wang, Yunyun Chen, Ming Lu*. Pterostilbene-nicotinamide cocrystal: A case reported of single crystals grown from melt micro droplets. Crystal Growth & Design, 2023, 23(1): 6-10. https://doi.org/10.1021/acs.cgd.2c01073
6. Xiao Ou,+ Shuting Li,+ Yunyun Chen, Haowei Rong, Ao Li, Ming Lu*. Polymorphism in griseofulvin: New story between an old drug and polyethylene glycol. Crystal Growth & Design, 2022, 22, 6: 3778-3785. https://doi.org/10.1021/acs.cgd.2c00156 (Highlighted as the outside front cover)
7. Molly Lightowler,+ Shuting Li,+ Xiao Ou, Xiaodong Zou, Ming Lu,* Hongyi Xu.* Indomethacin polymorph δ revealed to be two plastically bendable crystal forms by 3D electron diffraction: Correcting a 47-year-old misunderstanding. Angewandte Chemie International Edition, 2022, 61(7): e202114985, https://doi.org/10.33774/chemrxiv-2021-s9fhf (Highlighted as the outside front cover)
8. Huanyue Zhou, Yu Wang, Shuting Li, Ming Lu.* Improving chemical stability of resveratrol in hot melt extrusion based on formation of eutectic with nicotinamide. International Journal of Pharmaceutics, 2021, 607: 121042. https://doi.org/10.1016/j.ijpharm.2021.121042
9. Xizhen Li,+ Xiao Ou,+ Bingquan Wang,+ Haowei Rong, Bing Wang, Chao Chang, Baimei Shi, Lian Yu, Ming Lu*. Rich polymorph in nicotinamide revealed by melt crystallization and crystal structure prediction. Communications Chemistry, 2020, 3, 152. https://doi.org/10.1038/s42004-020-00401-1
10. Xizhen Li, Xiao Ou, Haowei Rong, Siyong Huang, Jonas Nyman, Lian Yu, Ming Lu.* The twelfth solved structure of ROY: Single crystals of Y04 grown from melt microdroplets. Crystal Growth & Design. 2020, 20(11): 7093-7097. https://doi.org/10.1021/acs.cgd.0c01017 (Highlighted as the outside front cover)
11. Xiao Ou,+ XizhenLi,+ Haowei Rong, Lian Yu, Ming Lu*. A general method for cultivating single crystals from melt micro droplets. Chemical Communications, 2020, 56: 9950-9953. https://doi.org/10.1039/D0CC03157G
12. Deen Huang, Ziyuan Xie, Qiuhong Rao, Evangelos Liamas, Piaopiao Pan, Shixia Guan*, Zhenyu Jason Zhang, Ming Lu*, Qingguo Li*. Hot melt extrusion of heat-sensitive and high melting point drug: Inhibit the recrystallization of the prepared amorphous drug during extrusion to improve the bioavailability. International Journal of Pharmaceutics, 2019, 565: 316-324. https://doi.org/10.1016/j.ijpharm.2019.04.064
13. Zhengwei Huang, Ling Lin, Cushla McGoverin, Hu Liu, Lili Wang, Qi (Tony) Zhou, Ming Lu*, Chuanbin Wu. Dry powder inhaler formulations of poorly water-soluble itraconazole:A balance between in-vitro dissolution and in-vivo distribution is necessary. International Journal of Pharmaceutics, 2018,551(1-2): 103-110. https://doi.org/10.1016/j.ijpharm.2018.09.018
14. Yongcheng Li, Ming Lu*, Chuanbin Wu*. PVP VA64 as a novel release-modifier for sustained-release mini-matrices prepared via hot melt extrusion. Drug Delivery and Translation Research. 2018, 8(6): 1670-1678. https://doi.org/10.1007/s13346-017-0437-9
15. Ling Lin, Guilan Quan, Tingting Peng, Zhengwei Huang, Vikramjeet Singh, Ming Lu*, Chuanbin Wu*. Development of fine solid-crystal suspension with enhanced solubility, stability, and aerosolization performance for dry powder inhalation. International Journal of Pharmaceuticals. 2017, 533(1): 84-92. https://doi.org/10.1016/j.ijpharm.2017.09.024
16. Ming Lu, Lynne S*. Taylor. Vemurafenib: A tetramorphic system displaying concomitant crystallization from the supercooled liquid. Crystal Growth & Design, 2016, 16 (10): 6033–6042. https://doi.org/10.1021/acs.cgd.6b01066
17. Pin Dong, Ling Lin, Yongcheng Li, Zhengwei Huang, Tianqun Lang, Chuanbin Wu*, Ming Lu*. In-situ synchrotron wide-angle X-ray diffraction as a rapid method for cocrystal/salt screening. International Journal of Pharmaceutics. 2015, 496(1): 107-116. https://doi.org/10.1016/j.ijpharm.2015.03.045
18. Ming Lu, Zhefei Guo, Yongcheng Li, Huishi Pang, Ling Lin, Xin Pan*, Chuanbin Wu*. Application of hot melt extrusion for poorly water-soluble drugs: Limitations, Advances and Future prospects. Current Pharmaceutical Design. 2014, 20(3):369-387. http://doi.org/10.2174/13816128113199990402
19. Zhefei Guo, Ming Lu*, Yongcheng Li, Huishi Pang, Ling Lin, Xu Liu, Chuanbin Wu*. The utilization of drug-polymer interactions for improving the chemical stability of hot-melt extruded solid dispersions. Journal of Pharmacy and Pharmacology. 2014, 66(2): 285-296. https://doi.org/10.1111/jphp.12145
20. Yongcheng Li, Huishi Pang, Zhefei Guo, Ling Lin, Yixuan Dong, Ge Li, Ming Lu*, Chuanbin Wu. Interactions between drugs and polymers influencing hot melt extrusion. Journal of Pharmacy and Pharmacology. 2014, 66(2): 148-166. https://doi.org/10.1111/jphp.12183
21. Xu Liu, Ming Lu*, Zhe fei Guo, Lin Huang, Xin Feng, Chuanbin Wu*. Improving the chemical stability of amorphous solid dispersion with cocrystal technique by hot melt extrusion. Pharmaceutical Research. 2012, 29(3): 806-817. https://doi.org/10.1007/s11095-011-0605-4
(+ Equal contribution, * Corresponding author)
授權專利
1. 陸明,李錫祯,歐霄。化合物單晶及其制備方法。專利号:CN112239890B。(授權日期:2022年6月21日)
2. 陸明,黃思詠,李錫祯,歐霄。化合物單晶及其制備方法。專利号:CN112250663B。(授權日期:2022年8月19日)
3. 吳傳斌,董品,陸明。 伊曲康唑的固體分散體制備方法和應用。專利号:201510460617.6。(授權日期:2018年2月5日)
4. 吳傳斌,林玲,陸明。伊曲康唑吸入粉霧劑及其制備方法。專利号:CN 104398497B。(授權日期:2017年11月24日)
5. 吳傳斌,陸明,黎永誠。富馬酸喹硫平緩釋制劑及其制備方法。專利号:ZL201410232678.2。(授權日期:2017年10月3日)
6. 吳傳斌,陸明,郭喆霏。二氟尼柳固體分散體及其制備方法。專利号:CN 103202811A。(授權日期:2015年4月15日)
7. 吳傳斌,劉旭,陸明。一種難溶性藥物共晶固體分散體及其制備方法。專利号:CN 102188365 B。(授權日期:2012年12月5日)
主持科研項目
1. 廣東省自然科學基金面上項目。剪切流動誘導無定形藥物成核及其分子機制研究,2024.1-2026.12。(主持,在研)
2. 廣東省自然科學基金面上項目。腸道pH變化所緻的克唑替尼原位凝膠化及其機制研究,項目編号2022A1515010393,2021.1-2024.12。(主持,在研)
3. 廣州市基礎研究計劃基礎與應用基礎研究項目。聚合物熔體高效誘導藥物新晶型的分子機制研究,項目編号202102080327,2020.1-2022.12。(主持,結題)
4. 廣東省自然科學基金面上項目。基于過冷熔體高效篩選磺酰脲類和格列奈類降糖藥物的潛在優勢晶型及其調控機制研究,項目編号2020A151501782,2020.3-2023.3。(主持,結題)
5. 廣東省自然科學基金面上項目。基于小分子氫鍵組份的熱敏性藥物熔融溫度調控及其在熱熔擠出過程中穩定機制研究,項目編号2018A030313335,2018.5-2021.4。 (主持,結題)
6. 廣東省新藥設計與評價重點實驗室開放基金科研項目。基于過冷液體的藥物多晶型研究,2018.9-2020.9。(主持,結題)
7. 國家自然科學基金面上青年基金。基于尺寸效應的剪切誘導聚合物晶型轉變研究,項目編号51103184, 2012.1.-2014.12。(主持,結題)
8. 高校基本業務費青年教師培育項目。基于熱熔擠出的藥物-聚合物相互作用研究,項目編号12ykpy08, 2012.12.1.-2015.12.1。(主持,結題)
9. 廣東省醫學科研基金。熱熔擠出構建伊曲康唑幹粉吸入劑及其體内外評價,項目編号A2015169,2015.6-2017.6。(主持,結題)
歡迎加入Lu Lab!